Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02707601
Brief Title: Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV Treatment (Co-STARs)

First Submitted : March 9, 2016
First Submitted that Met QC Criteria : March 9, 2016
First Posted : March 14, 2016 (Estimate)

Results First Submitted : September 12, 2018
Results First Submitted that Met QC Criteria : September 12, 2018
Results First Posted : October 9, 2018

Last Update Submitted that Met QC Criteria : October 19, 2018
Last Update Posted : November 14, 2018